Company intelligence / Profile preview
Arrowhead Pharmaceuticals
Pasadena, California, United Statesarrowheadpharma.com ↗
- Ownership
- Public · ARWR
- Employees
- ~376
- Development stage
- Phase 3
01
Overview
Arrowhead’s lead asset plozasiran achieved successful topline results in the pivotal Phase 3 PALISADE study for familial chylomicronemia syndrome. The New Drug Application was accepted by the FDA with a PDUFA date set for November 2025. Additional late-stage programs target severe hypertriglyceridemia and mixed hyperlipidemia. The company has a broad pipeline leveraging its proprietary TRiM™ RNAi platform across cardiometabolic, liver-related rare diseases, pulmonary conditions, hepatitis B infection and genetic muscle disorders. Several assets are partnered with major pharmaceutical companies.
- Therapeutic areas
- Metabolic DisordersPulmonologyGastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- RNA interference (RNAi) therapeutics
- Industry
- Biotech
02
Drug pipeline
36 assets35 more assets in the full pipeline.
03
Partnerships
Amgen – cardiovascular collaboration/licensing agreement for ARO-LPA & ARO-AMG1Janssen – $3.7B license/collaboration agreement for ARO-HBV & up to three additional targetsTakeda – partnership on fazirsiranSarepta Therapeutics – recent licensing/collaboration agreement covering neuromuscular assets outside core focus area
04
Financials
- Market cap
- $8.1B
- Total revenue
- $829.4M
- Enterprise value
- $7.4B
Beyond the preview
Go deeper on Arrowhead Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Arrowhead Pharmaceuticals.